Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Clinical Immunology
Published in: Journal of Clinical Immunology 4/2019

01-05-2019 | Vasculitis | Letter to Editor

Recurrent Salmonella typhi Infection and Autoimmunity in a Young Boy with Complete IL-12 Receptor β1 Deficiency

Authors: Ankur Kumar Jindal, Deepti Suri, Sandesh Guleria, Amit Rawat, Sumit Garg, Amanjit Bal, Jean-Laurent Casanova, Jacinta Bustamante, Surjit Singh

Published in: Journal of Clinical Immunology | Issue 4/2019

Login to get access

Excerpt

To the Editor …
Appendix
Available only for authorised users
Literature
1.
Bustamante J, Boisson-Dupuis S, Abel L, Casanova J-L. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity. Semin Immunol. 2014;26(6):454–70.CrossRefPubMedPubMedCentral
2.
3.
Sogkas G, Atschekzei F, Schacht V, von Falck C, Jablonka A, Jacobs R, et al. First association of interleukin 12 receptor beta 1 deficiency with Sjögren’s syndrome. Front Immunol. 2017;28:8.
4.
Filiz S, Kocacik Uygun DF, Verhard EM, van Dissel JT, Uygun V, Bassorgun C, et al. Cutaneous leukocytoclastic vasculitis due to Salmonella enteritidis in a child with interleukin-12 receptor beta-1 deficiency. Pediatr Dermatol. 2014;31(2):236–40.CrossRefPubMed
5.
Kutukculer N, Genel F, Aksu G, Karapinar B, Ozturk C, Cavusoglu C, et al. Cutaneous leukocytoclastic vasculitis in a child with interleukin-12 receptor beta-1 deficiency. J Pediatr. 2006;148(3):407–9.CrossRefPubMed
6.
Khamassi I, Ben Ali M, Ben Mustapha I, Barbouche MR, Bejaoui M, Bouyahia O, et al. Salmonella enteriditis inducing cutaneous leucocytoclasic vasculitis: an unusual complication in a patient with an interleukine- 12 receptor beta-1 deficiency. Tunis Med. 2015;93(5):328–9.PubMed
7.
Ling G, Ling E, Broides A, Poran Feldman H, Levy J, Garty B-Z, et al. IL-12 receptor 1β deficiency with features of autoimmunity and photosensitivity. Autoimmunity. 2016;49(3):143–6.CrossRefPubMed
8.
Göktürk B, Reisli İ, Çalışkan Ü, Oleaga-Quintas C, Deswarte C, Turul-Özgür T, et al. Infectious diseases, autoimmunity and midline defect in a patient with a novel bi-allelic mutation in IL12RB1 gene. Turk J Pediatr. 2016;58(3):331–6.CrossRefPubMed
9.
Nekooie-Marnany N, Deswarte C, Ostadi V, Bagherpour B, Taleby E, Ganjalikhani-Hakemi M, et al. Impaired IL-12- and IL-23-mediated immunity due to IL-12Rβ1 deficiency in Iranian patients with mendelian susceptibility to mycobacterial disease. J Clin Immunol. 2018;38(7):787–93.CrossRefPubMed
10.
de Beaucoudrey L, Samarina A, Bustamante J, Cobat A, Boisson-Dupuis S, Feinberg J, et al. Revisiting human IL-12Rβ1 deficiency. Medicine (Baltimore). 2010;89(6):381–402.CrossRef
11.
Dionisio D, Esperti F, Vivarelli A, Fabbri C, Apicella P, Meola N, et al. Acute terminal ileitis mimicking Crohn’s disease caused by Salmonella veneziana. Int J Infect Dis. 2001;5(4):225–7.CrossRefPubMed
12.
Papanikolaou IS, Psilopoulos DI, Liatsos C, Lazaris AC, Petraki K, Mavrogiannis C. Salmonella colitis or inflammatory bowel disease? A case demonstrating overlapping of clinical, endoscopic and pathologic features. Ann Gastroenterol. 2001;14(1):65–9.
13.
Sanal O, Turul T, De Boer T, Van de Vosse E, Yalcin I, Tezcan I, et al. Presentation of interleukin-12/23 receptor beta1 deficiency with various clinical symptoms of Salmonella infections. J Clin Immunol. 2006;26(1):1–6.CrossRefPubMed
14.
15.
Metadata
Title
Recurrent Salmonella typhi Infection and Autoimmunity in a Young Boy with Complete IL-12 Receptor β1 Deficiency
Authors
Ankur Kumar Jindal
Deepti Suri
Sandesh Guleria
Amit Rawat
Sumit Garg
Amanjit Bal
Jean-Laurent Casanova
Jacinta Bustamante
Surjit Singh
Publication date
01-05-2019
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 4/2019
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-019-00637-0

Other articles of this Issue 4/2019

Journal of Clinical Immunology 4/2019 Go to the issue

Original Article

A Unique Presentation of Infantile-Onset Colitis and Eosinophilic Disease without Recurrent Infections Resulting from a Novel Homozygous CARMIL2 Variant

Letter to Editor

Variable Responses to Tocilizumab in Four Patients with Schnitzler Syndrome

Original Article

Factors Beyond Lack of Antibody Govern Pulmonary Complications in Primary Antibody Deficiency

Letter to Editor

Fifteen Years of the J Project

Original Article

Role of Allogeneic Hematopoietic Stem Cell Transplant for Chronic Granulomatous Disease (CGD): a Report of the United States Immunodeficiency Network

CME Reviews

Life-Threatening Infections Due to Live-Attenuated Vaccines: Early Manifestations of Inborn Errors of Immunity
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits